Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22595799

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2012 May 19
First author
van der Graaf WT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 May 19;379(9829):1854-6. doi: 10.1016/S0140-6736(12)60739-9.
    note
    Source null
    related pmid
    22595798
    relationship
    Comment in
  2. citation
    Lancet. 2012 Sep 1;380(9844):801; author reply 801. doi: 10.1016/S0140-6736(12)61440-8.
    note
    Source null
    related pmid
    22939674
    relationship
    Comment in

Authors and identifiers

  1. name
    van der Graaf WT
    type
    Author
  2. name
    Blay JY
    type
    Author
  3. name
    Chawla SP
    type
    Author
  4. name
    Kim DW
    type
    Author
  5. name
    Bui-Nguyen B
    type
    Author
  6. name
    Casali PG
    type
    Author
  7. name
    Schöffski P
    type
    Author
  8. name
    Aglietta M
    type
    Author
  9. name
    Staddon AP
    type
    Author
  10. name
    Beppu Y
    type
    Author
  11. name
    Le Cesne A
    type
    Author
  12. name
    Gelderblom H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    van der Graaf WT
    type
    Author
  2. name
    Blay JY
    type
    Author
  3. name
    Chawla SP
    type
    Author
  4. name
    Kim DW
    type
    Author
  5. name
    Bui-Nguyen B
    type
    Author
  6. name
    Casali PG
    type
    Author
  7. name
    Schöffski P
    type
    Author
  8. name
    Aglietta M
    type
    Author
  9. name
    Staddon AP
    type
    Author
  10. name
    Beppu Y
    type
    Author
  11. name
    Le Cesne A
    type
    Author
  12. name
    Gelderblom H
    type
    Author
bibliography ids
  1. nci-bib-594770a40003a861d64676e1
book metadata
content sha256
aefa4cd728520e51eca02f8cb96d1c421252d0472369258783aa24a3971004d6
document type
citation
dois
  1. 10.1016/S0140-6736(12)60651-5
electronic publication date
display
2012 May 16
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22595799
immutable id
pubmed:22595799@aefa4cd728520e51eca02f8cb96d1c421252d0472369258783aa24a3971004d6
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9829
name
Lancet (London, England)
nlm unique id
2985213R
pages
1879-86
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 May 19;379(9829):1854-6. doi: 10.1016/S0140-6736(12)60739-9.
    note
    Source null
    related pmid
    22595798
    relationship
    Comment in
  2. citation
    Lancet. 2012 Sep 1;380(9844):801; author reply 801. doi: 10.1016/S0140-6736(12)61440-8.
    note
    Source null
    related pmid
    22939674
    relationship
    Comment in
outcomes validated
false
pmid
22595799
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
f22c3b68b658dd38d7db5e1ec2f8122d220cf32ce8b9a7b8c3a04a79b1d3fff6
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 May 19
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22595799/
title
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

Preserved source evidence · Not medical advice